Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702500 | Urologic Oncology: Seminars and Original Investigations | 2017 | 12 Pages |
Abstract
Many patient- and system-related determinants were identified as contributing to the overuse of advanced imaging to stage low-risk prostate cancer. Overuse may be the consequence of systematized clinician behavior and be relatively invariant of patient characteristics. The identified system-level determinants suggest that payment models that are not tied to volume or that reward, enhanced care co-ordination may curb overuse. We propose further examination of physician-level determinants and implore researchers to rank the relative importance of the identified factors and to test their influence through experimental and quasi-experimental methods.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Allison H. B.A., Ritu B.Sc., Madeline M.P.H., Jodi B. M.D., M.P.H.,